전 세계 혈압계 커프 시장 규모는 예측 기간 동안 7.13%의 CAGR로 2024년 8억 7,788만 달러에서 2032년에는 15억 2,308만 달러로 성장할 것으로 예상됩니다.
고혈압 및 심혈관질환의 증가, 노인 인구의 증가, 의료기기의 발전 등을 배경으로 전 세계 혈압계 커프스 시장이 확대되고 있습니다. 세계보건기구(WHO)의 2023년 3월 추산에 따르면, 30-79세 성인 약 12억 8,000만 명이 고혈압을 앓고 있으며, 이 중 66% 이상이 중저소득 국가에 집중되어 있습니다. 특히 주목할 만한 점은 고혈압 환자의 46%가 진단을 받지 못하고 있다는 점입니다.
혈압계 커프 시장은 고혈압 환자의 증가와 가정용 모니터링 기기의 기술 혁신으로 인해 안정적인 성장세를 보이고 있습니다. 디지털 및 스마트 혈압 커프는 모바일 건강 앱과 연동할 수 있는 편의성으로 인해 인기가 높아지고 있으며, 수동 혈압계 커프는 의료 현장에서 널리 사용되고 있습니다. 또한, 병원에서는 감염 예방 대책으로 일회용 커프의 사용이 증가하고 있는 것도 시장 확대의 한 요인으로 작용하고 있습니다.
북미가 높은 의료 인프라를 바탕으로 선두를 달리고 있으며, 아시아태평양도 의료 접근성 향상과 고혈압에 대한 인식 확대에 따라 시장 점유율을 놓고 경쟁하고 있습니다. 향후 몇 년간 시장 성장은 주요 업체들이 기존 제품에 AI 기술을 도입하고 웨어러블 혈압 모니터를 강화하는 데 주력하면서 촉진될 것으로 예상됩니다. 또한, 원격의료 및 원격 환자 모니터링 분야가 확대됨에 따라 혈압계 커프는 건강 증진 및 만성질환 관리의 중요한 도구로서 전 세계적으로 수요가 증가할 것으로 예상됩니다.
세계의 혈압계 커프 시장을 조사했으며, 시장 정의와 개요, 시장 규모 동향 및 예측, 각종 분류별 상세 분석, 산업 구조, 시장 성장 촉진요인 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.
Global blood pressure cuffs market is projected to witness a CAGR of 7.13% during the forecast period 2025-2032, growing from USD 877.88 million in 2024 to USD 1523.08 million in 2032. The global blood pressure cuffs market is expanding due to a rise in hypertension and cardiovascular diseases, alongside the elderly population and healthcare device advancements. According to World Health Organization (WHO) estimates in March 2023, around 1.28 billion adults aged 30-79 worldwide is affected by hypertension, with more than 66% of cases found in low- and middle-income nations. Significantly, 46% of adults suffering from hypertension have not been diagnosed.
The blood pressure cuffs market demonstrates a consistent rise because hypertension patients are increasing alongside innovations in home monitoring devices. Digital and smart blood pressure cuffs experience increasing popularity as they work smoothly with mobile health applications, but sphygmomanometer-style blood pressure cuffs remain widely used in medical settings. The increasing use of disposable blood pressure cuffs in hospitals for infection prevention drives the market's expansion. North America leads the market growth due to its advanced healthcare facilities, while Asia-Pacific competes for market domination because healthcare accessibility is expanding and hypertension awareness is growing. Market growth in the upcoming years continues as major companies focus on enhancing wearable BP monitor devices by incorporating AI technology in existing products, which creates new market opportunities. The expanding telemedicine and remote patient monitoring sectors will drive blood pressure cuff market growth because these devices serve as vital tools for worldwide health promotion and chronic disease management.
Additionally, to meet the increasing cases of high blood pressure disease among different age groups, companies such as PyrAmes Inc. obtained FDA grant clearance in October 2023 for its path-breaking Boppli platform, which safely measures the blood pressure of critically ill infants.
Growing Awareness in Home Care Settings
The rising demand for portable and preventive healthcare devices, rising awareness concerning hypertension, and the development of home blood pressure cuff devices are driving global market growth. Doctors now often advise their patients to use home blood pressure monitoring devices following the telemedicine expansion, which has resulted in increased at-home monitoring. Manufacturers designed modern devices with effortless operation features and display clarity while creating health app connections. The rise in population understanding about hypertension from government educational schemes and pharmacy training initiatives has increased the market demand for high blood pressure monitoring devices. People in contemporary society view blood pressure cuffs as fundamental components for medical self-care in place of conventional hospital equipment. An accelerating shift toward self-managed healthcare alongside improved reimbursement for virtual patient education has established home healthcare as the leading blood pressure monitoring market segment.
Home healthcare sector expansion motivates companies to launch new products, which aim to acquire more market space and create revenue growth. For instance, the United States market benefitted from the at-home blood pressure monitoring device BPM Vision from Withings SAS in April 2025 after obtaining FDA approval. The advanced monitor consists of a USB-C rechargeable battery and a user-friendly LCD screen that automatically synchronizes with the Withings mobile application that supports iOS, Android, Apple Health, and Samsung Health systems.
Technology Advancement Boosts Global Blood Pressure Cuffs Market Demand
The blood pressure cuff market experiences significant growth owing to the introduction of advanced technology, which brings about intelligent and highly precise integrated devices. The adoption of digital and wireless solutions in blood pressure cuffs enables real-time health monitoring via smartphone apps and virtual healthcare systems because this technology aligns with the rising need for telemedicine. AI-enabled blood pressure cuffs now provide predictive functions that enable early hypertension detection even before any symptoms become apparent. Every day, users benefit from smart technology through straightforward designs that enable compact use and one-touch operation and provide extended battery life to avoid complicated multi-button interfaces. Specialized healthcare innovations include antimicrobial disposable cuffs along with ECG and SpO2 monitoring devices for comprehensive health assessment in clinical environments.
For instance, in April 2025, Becton, Dickinson and Company (BD) released the HemoSphere Alta platform, representing a notable advancement in hemodynamic monitoring technology. This next-generation platform includes sensors enabled by smart algorithms to provide generalized and personalized insights into a patient's hemodynamics, improving patient care in many clinical environments.
Adults Holds Largest Global Blood Pressure Cuffs Market Share
Adults hold the largest market segment in the global blood pressure cuffs market, as individuals face elevated risks of hypertension and cardiovascular disease compared to younger individuals. The increasing prevalence of different diseases, including obesity and diabetes, and stress levels among adults, is driving the demand for blood pressure cuffs globally. These devices experience their highest usage among elderly adults who need frequent blood pressure monitoring due to their ongoing medical conditions. Also, the healthcare field has embraced a new approach to monitor adult patients who require ongoing blood pressure control, which propels market growth significantly. Furthermore, different companies and organizations globally are encouraging the usage of innovative blood pressure cuffs to avoid delays and better treatment.
For instance, in November 2024, the American Heart Association promoted AI-powered tools to identify changes in blood flow in the skin on the face and hands may provide a novel form of screening for high blood pressure and diabetes without blood pressure cuffs, blood tests, or wearable devices.
North America Dominates the Blood Pressure Cuffs Market Share
North America holds a significant share of the global blood pressure cuffs market because it possesses state-of-the-art medical facilities, experiences high rates of hypertension, and demonstrates early acceptance of modern medical tools. Digital and connected blood pressure monitoring technologies receive market support from the U.S. and Canada-based manufacturers who maintain their leading market positions. The region's shift from mercury-based devices to digital products supports worldwide health movements and enhances its market standing. Through company partnerships with healthcare institutions and rising research and development funding, the North American market solidifies its leadership position in this industry.
For instance, in North America, in January 2023, Cardinal Health teamed up with Palantir Technologies to create a data-driven solution that is embedded in Palantir's Foundry operating system. Through this partnership, Cardinal Health applies artificial intelligence and machine learning technologies to provide immediate healthcare system and hospital insights that lead to better pharmaceutical purchases and improved supply chain performance, and pharmacy inventory control.
Impact of U.S. Tariffs on Blood Pressure Cuffs Market
U.S. tariffs have caused major disruptions to the worldwide blood pressure cuff market through their effects on supply chain operations and cost structure. The tariffs on blood pressure cuffs have pushed companies to establish new manufacturing sites outside of China because this country produces a large quantity of these medical devices, which disrupts their operational model and supply chain network. While manufacturers on the sidelines can grapple with the added cost, others have had to pass on the costs to consumers, potentially influencing the affordability and accessibility of the product. The result of this shift may cause Chinese producers to focus on non-U.S. markets and consequently change the competition in Europe and Asia. U.S. and European brands will focus on effective operations to mitigate costs. Finally, the tariffs may deter innovation as companies are more concerned with cutting costs rather than with advanced features.
Key Players Landscape and Outlook
Continuous innovation characterizes the landscape of blood pressure cuffs globally, as companies compete to outperform one another by launching wearable blood pressure technology, AI & Data analytics integration, and shifting towards disposable to antimicrobial cuffs to maintain the market trends and become the topper in the market. Companies are also shifting towards collaborations, and developing technologies are projected to increase competition in this fast-paced market. The growing demand for blood pressure cuffs due to the rising hypertension and cardiovascular disease also helps players to generate revenue.
For instance, in November 2024, Omron Healthcare, Inc. received FDA De Novo marketing authorization for its AI-enabled blood pressure monitors with IntelliSense AFib algorithms that automatically analyze the pressure pulse wave created while taking a blood pressure measurement to identify AFib, a significant risk factor for stroke.
For instance, in May 2025, Baxter International Inc. reported that to understand the supply constraints of Baxter's Welch Allyn Flexiport Disposable blood pressure cuffs, Baxter expanded its manufacturing capacity with the installation of a new domestic production line in 2025. The action was to meet elevated demand and have improved supply chain flexibility.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.